Positive outlook for Symrise

Symrise reports extensive growth in 2014 fiscal yearIn the fiscal year 2014, the global supplier exceeded its targets and substantially expanded its market position. It benefited from good demand in all regions and in both segments as well as from a particularly strong performance in the fourth quarter. In addition, with the acquisition of the Diana Group in July 2014, it succeeded in entering the baby food and pet food markets and was able to expand its portfolio of natural ingredients.

For the full year, group sales increased by 18 per cent at local currency to €2,120.1 million (2013: €1,830.4 million). Earnings before interest, taxes, depreciation and amortisation as normalised for one-time effects from the acquisition and integration of Diana (EBITDAN) increased by 24 per cent to €464.5 million (2013: € 373.1 million). With an EBITDAN margin of 21.9 per cent (2013: 20.4 per cent), Symrise ranks again among the most profitable companies in the industry. 

CEO Dr Heinz-Jürgen Bertram comments: ‘Last year was a very successful one for Symrise. We considerably expanded our market position in mature and emerging markets and significantly broadened our portfolio of natural ingredients through the acquisition of Diana. Most importantly, we once more created value and substantially increased sales, earnings and profitability. As a result, we are in an excellent position, both strategically and financially, to continue our profitable growth in 2015 and to outperform the market again.’ 

Double digit growth

The strongest region in terms of sales growth in fiscal year 2014 was again Latin America, followed by EAME, with sales increases of 27 per cent and 21 per cent respectively (both at local currency). The third-strongest region, with a gain of 17 per cent at local currency, was North America, followed by the Asia/Pacific region, where sales grew by 10 per cent. 

The Scent & Care segment continued to focus on high-margin business in 2014. The segment increased sales in local currency by four per cent to €980.4 million (2013: €960.4 million); in the reporting currency, this represents an increase of two percent. Scent & Care made very satisfactory gains, especially with cosmetic ingredients. It also grew its EBITDA by 15 per cent to € 222.9 million (2013: €194.5 million). The EBITDA margin increased by 2.4 percentage points to 22.7 per cent (2013: 20.3 per cent). 

Long term goals on track 

In the current fiscal year, the group expects to benefit from solid customer demand and high capacity utilisation in both segments as well as in mature and emerging markets. Prices of raw materials will continue to influence the cost development in 2015. Although the costs of chemical commodities were down at the end of 2014, prices of various agricultural raw materials showed significant increases. Consequently, Symrise expects continued volatility in raw material prices as well as certain currencies. According to estimates, the global market for fragrances and flavors is growing at two to three per cent per year. For 2015, it remains committed to its goal of growing faster than the market and achieving an EBITDA margin of over 20 per cent.

 

In addition, Symrise confirms the objectives defined for the fiscal year 2020, namely a compound annual growth rate (CAGR) of five to seven per cent and an EBITDA margin in the range of 19 to 22 per cent.



Latest


25 Sep 2020
New dates for MAGHREB PHARMA

Easyfairs Northeral, the organiser of MAGHREB PHARMA Expo has announced new dates for its annual international tradeshow for the pharmaceutical…

New dates for MAGHREB PHARMA

Easyfairs Northeral, the organiser of MAGHREB PHARMA Expo has announced new dates for its annual international tradeshow for the pharmaceutical industry in North Africa. In this context, the Algerian Pharmaceutical Industry Minister, Lotfi Benbahmed, announced end of August in Algiers that Algeria plans to export the equivalent of $ 5…

25 Sep 2020
Are you the next generation of brave healthcare professionals?

Season 2 of ‘Sponsors of Brave’ is now open for nominations.  The 2020 Sponsors of Brave campaign – a partnership…

Are you the next generation of brave healthcare professionals?

Season 2 of ‘Sponsors of Brave’ is now open for nominations.  The 2020 Sponsors of Brave campaign – a partnership between Adcock Ingram OTC and News24 – aims to celebrate the unsung heroes and brave professionals in healthcare. In particular, season 2 recognises that pursuing a career in healthcare during…

25 Sep 2020
How data sciences will help you get optimum value from your factory floor

Industry 4.0 and IIoT have been buzz words for several years and these concepts are actually implemented on more and more machines.  …

How data sciences will help you get optimum value from your factory floor

Industry 4.0 and IIoT have been buzz words for several years and these concepts are actually implemented on more and more machines.   A huge amount of data becomes available: machine data, data of the production process and data regarding the manufactured product. Big Data has entered the factory floor.  Data pipeline   Data…

23 Sep 2020
Merck expands its ADC manufacturing capabilities

Merck has announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility…

Merck expands its ADC manufacturing capabilities

Merck has announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. This investment will allow large-scale manufacturing of increasingly potent compounds for therapies that have the potential to treat cancer. Completion is expected by mid-2022 and should…


Top stories


23 Apr 2020
Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love.…

Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love. Santam, Fairlady and, for the first time this year, Truelove Magazine, have partnered up in the search to find the best female entrepreneurs in the country. Best women entrepreneurs If…

30 Nov 2017
Rooibos could reduce risk of “Type 3” diabetes – a precursor to Alzheimer’s

Researchers at Warren Alpert Medical School at Brown University in the US found a link between a relatively new form…

Rooibos could reduce risk of “Type 3” diabetes – a precursor to Alzheimer’s

Researchers at Warren Alpert Medical School at Brown University in the US found a link between a relatively new form of diabetes, known as “type 3” diabetes and Alzheimer’s disease.

25 Jun 2020
How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a…

How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a changing environment, whether it be internal or external. Qualities of agile businesses include being adaptive, flexible and creative in your response to change without losing momentum (remaining productive) or vision.…

01 May 2020
Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex,…

Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex, which continuously invests in technological advancements to meet requirements in diverse industries – has increased production capacity of materials so desperately needed during the global COVID-19 pandemic,” explains Rosa Naidoo,…


Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za